TriSalus Life Sciences (TLSI) Share-based Compensation (2022 - 2026)
TriSalus Life Sciences has reported Share-based Compensation over the past 5 years, most recently at $2.5 million for Q1 2026.
- For Q1 2026, Share-based Compensation rose 52.59% year-over-year to $2.5 million; the TTM value through Mar 2026 reached $10.0 million, up 67.08%, while the annual FY2025 figure was $9.1 million, 67.82% up from the prior year.
- Share-based Compensation for Q1 2026 was $2.5 million at TriSalus Life Sciences, up from $2.2 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $3.4 million in Q3 2025 and troughed at $68000.0 in Q2 2023.
- A 5-year average of $1.3 million and a median of $1.3 million in 2024 define the central range for Share-based Compensation.
- Biggest five-year swings in Share-based Compensation: skyrocketed 1775.0% in 2024 and later rose 29.46% in 2025.
- Year by year, Share-based Compensation stood at $117000.0 in 2022, then soared by 754.7% to $1.0 million in 2023, then surged by 69.7% to $1.7 million in 2024, then increased by 29.46% to $2.2 million in 2025, then increased by 12.52% to $2.5 million in 2026.
- Business Quant data shows Share-based Compensation for TLSI at $2.5 million in Q1 2026, $2.2 million in Q4 2025, and $3.4 million in Q3 2025.